Alnylam Pharmaceuticals, Inc. ( ALNY) - Key Metrics
ALNY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $8.30 | $1.41 | $1.24 | $1.06 |
| 2025Q3 | $9.50 | $1.91 | $2.47 | $2.38 |
| 2025Q2 | $5.97 | -$0.51 | $1.19 | $1.08 |
| 2025Q1 | $4.58 | -$0.44 | -$0.91 | -$0.98 |
ALNY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 70.52 |
| 2025Q3 | ? | 59.68 |
| 2025Q2 | ? | -159.50 |
| 2025Q1 | ? | -152.30 |
ALNY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.11% | ? |
| 2025Q4 | 0.27% | ? |
| 2025Q3 | 0.52% | ? |
| 2025Q2 | 0.33% | ? |
| 2025Q1 | -0.36% | ? |
ALNY
Price: $271.77
52 week price:
Earnings Per Share: 3.97 USD
P/E Ratio: 76.32
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 712302
Ebitda: -143.6 millionMarket Capitalization: 41.8 billion